Clinical Research Directory
Browse clinical research sites, groups, and studies.
TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Summary
To offer the possibility of a treatment that could achieve a meaningful reduction in the incidence of post-radiation therapy hypothyroidism. Thyroid dysfunction may develop from a few months to several years after patients have completed their radiation treatment. In children with chronic diseases, or given lengthy anti-neoplastic treatments, recurrent or persistent endocrine disorders may have a negative effect on growth and development into adulthood.
Official title: Protection From Iatrogenic Hypothyroidism Patients With MBL and Pediatric Patients With HL and Non-HL Needing Radiotherapy on Thyroid Site
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
68
Start Date
2021-12-13
Completion Date
2029-09-30
Last Updated
2023-12-06
Healthy Volunteers
No
Conditions
Interventions
Levothyroxine
Levothyroxine is used to treat hypothyroidism (low thyroid function). This medicine is given when your thyroid does not produce enough of this hormone on its own.
Locations (1)
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy